Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 4.70 is 50% below its 5-year average of 9.36, near the low end of its 5-year range (2.19–17.99).
As of the fiscal period ended Tuesday, June 30, 2026. 13.54% above its 12-month average of 4.14.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 4.70.
CURRENT RATIO
4.70
CURRENT RATIO AVG TTM
4.14
CURRENT RATIO AVG 3Y
9.03
CURRENT RATIO AVG 5Y
9.36
CURRENT RATIO AVG 10Y
10.04
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+13.54%
CURRENT VS 3Y AVG
-47.90%
CURRENT VS 5Y AVG
-49.77%
CURRENT VS 10Y AVG
-53.15%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.59
median of 755 covered companies
CURRENT VS SECTOR MEDIAN
+30.99%
vs the sector median at left
Larimar Therapeutics, Inc.
Market Cap
$295.61M
Current Ratio
4.70
TTM Avg
4.14
3Y Avg
9.03
5Y Avg
9.36
Market Cap
$288.34M
Current Ratio
4.69
TTM Avg
11.27
3Y Avg
11.27
5Y Avg
11.27
Market Cap
$288.15M
Current Ratio
45.02
TTM Avg
28.56
3Y Avg
20.10
5Y Avg
23.41
Market Cap
$299.52M
Current Ratio
34.00
TTM Avg
44.34
3Y Avg
25.02
5Y Avg
19.51
Market Cap
$287.55M
Current Ratio
6.63
TTM Avg
6.50
3Y Avg
6.00
5Y Avg
4.95
Market Cap
$285.37M
Current Ratio
19.48
TTM Avg
1.73
3Y Avg
4.11
5Y Avg
4.35
Market Cap
$282.68M
Current Ratio
31.35
TTM Avg
25.02
3Y Avg
20.04
5Y Avg
16.03
Market Cap
$308.38M
Current Ratio
13.28
TTM Avg
4.54
3Y Avg
4.54
5Y Avg
4.54
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Larimar Therapeutics, Inc. (LRMR) | $295.61M | 4.70 | 4.14 | 9.03 | 9.36 |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $288.34M | 4.69 | 11.27 | 11.27 | 11.27 |
| Standard BioTools Inc. (LAB)vs › | $288.27M | 9.10 | 4.95 | 4.04 | 3.29 |
| Sagimet Biosciences Inc. (SGMT)vs › | $288.15M | 45.02 | 28.56 | 20.10 | 23.41 |
| Benitec Biopharma Inc. (BNTC)vs › | $299.52M | 34.00 | 44.34 | 25.02 | 19.51 |
| Abeona Therapeutics Inc. (ABEO)vs › | $287.55M | 6.63 | 6.50 | 6.00 | 4.95 |
| Indaptus Therapeutics, Inc. (INDP)vs › | $285.37M | 19.48 | 1.73 | 4.11 | 4.35 |
| Fulcrum Therapeutics, Inc. (FULC)vs › | $282.68M | 31.35 | 25.02 | 20.04 | 16.03 |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $308.38M | 13.28 | 4.54 | 4.54 | 4.54 |
| Aurora Cannabis Inc. (ACB)vs › | $279.05M | 5.36 | 5.13 | 3.92 | 3.90 |
Current Ratio
4.70
Quick Ratio
4.70
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 4.70 |
| 2026-03-31 | 4.29 |
| 2025-12-31 | 2.19 |
| 2025-09-30 | 4.06 |
| 2025-06-30 | 5.46 |
| 2025-03-31 | 7.48 |
| 2024-12-31 | 8.02 |
| 2024-09-30 | 13.10 |
| 2024-06-30 | 10.93 |
| 2024-03-31 | 17.99 |
| 2023-12-31 | 9.49 |
| 2023-09-30 | 15.02 |
| 2023-06-30 | 14.64 |
| 2023-03-31 | 14.17 |
| 2022-12-31 | 11.28 |
| 2022-09-30 | 13.50 |
| 2022-06-30 | 7.35 |
| 2022-03-31 | 7.31 |
| 2021-12-31 | 8.16 |
| 2021-09-30 | 7.88 |
| 2021-06-30 | 9.63 |
| 2021-03-31 | 10.28 |
| 2020-12-31 | 10.89 |
| 2020-09-30 | 20.82 |
| 2020-06-30 | 17.92 |
| 2020-03-31 | 6.56 |
| 2019-12-31 | 0.81 |
| 2019-09-30 | 5.11 |
| 2019-06-30 | 6.98 |
| 2019-03-31 | 0.32 |
| 2018-12-31 | 9.12 |
| 2018-09-30 | 11.78 |
| 2018-06-30 | 8.41 |
| 2018-03-31 | 12.26 |
| 2017-12-31 | 14.39 |
| 2017-09-30 | 13.60 |
| 2017-06-30 | 11.71 |
| 2017-03-31 | 13.81 |
| 2016-12-31 | 13.23 |
| 2016-09-30 | 12.49 |
| 2016-06-30 | 14.43 |
| 2016-03-31 | 13.11 |
| 2015-12-31 | 11.37 |
| 2015-09-30 | 15.17 |
| 2015-06-30 | 19.18 |
| 2015-03-31 | 24.80 |
| 2014-12-31 | 16.98 |
| 2014-09-30 | 11.14 |
| 2014-06-30 | 33.35 |
